Teva Launches Rise, Taps Startups for Pharma Innovation
The global drugmaker calls on startups to help tackle critical challenges in drug development, manufacturing, and patient care.
Merck to Acquire Cidara Therapeutics for $9.2 Billion in a Strategic Flu Prevention Initiative
The deal gives Merck a potential universal flu solution as the company prepares for a future beyond Keytruda.
UnitedHealth Banks on New Leadership to Regain Momentum
With a familiar leader back at the helm and a well-laid plan in place, UnitedHealth is working to steady its operations and deliver better results.
Just In: Boston Scientific Acquires Nalu Medical for $533 Million
The acquisition brings a novel neurostimulation device into Boston Scientific’s portfolio, expanding its capacity to provide effective solutions for chronic pain management.
Baxdrostat Breakthrough Offers New Hope for Resistant Hypertension
AstraZeneca’s Bax24 Phase III trial demonstrates sustained blood pressure control and a favorable safety profile in patients with treatment-resistant hypertension.
UnitedHealth Scales Back Medicare Advantage Plans in 16 Counties Amid Rising Program Costs and Funding Cuts
Industry analysts warn the move could signal broader consolidation and narrower choices for members in rural areas.
Novo Nordisk Freezes Hiring as Costs Rise Despite Wegovy FDA Approval
Cost-cutting move reflects margin squeeze and rising competition in the weight-loss drug market.
Spurt in Road Accidents Makes Advanced Critical Care Crucial to Save Victims in ‘Golden Hour’
Satellite technology enables emergency responders to pinpoint accident locations with extreme accuracy, even in remote areas.
Sword Health Raises $40M, Pushes IPO to 2028 as Growth Strategy Shifts
Although the company is cash-flow positive, it is postponing a public listing as it focuses on expanding its AI-driven care model and strengthening its position through private funding.